Company intelligence / Profile preview

Adli Tissue Regeneration

Ownership: Private
Development stage: Commercial

Overview

Adli Tissue Regeneration designs and manufactures individualized implants and surgical meshes with osseointegration capacity for patients with bone fractures or defects. The company leverages CT scan models to create custom implants using biomaterials that mimic natural bone properties. There are no published clinical results as of now; the company appears to be in the pre-clinical or early development stage[1][2][3][4].

Therapeutic areas: OtherRheumatology
Modalities: Polymer-based implantSurgical meshBiomaterial scaffold
Industry: Implantable Medical Devices

Drug pipeline

2 assets

Patient-specific bone implants

Commercial

Indications: Bone defects

1 more asset in the full pipeline.

Request access →

Partnerships

None publicly disclosed as of June 2025.

Beyond the preview

Go deeper on Adli Tissue Regeneration.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adli Tissue Regeneration.

Explore the full profile